These observations led to an interesting development bifurcation : Melanotan I (Afamelanotide) continued as a skin peptide and in 2014 received approval as Scenesse for erythropoietic protoporphyria (a rare genetic disease with severe photosensitivity) Melanotan II was abandoned as a cutaneous drug PT-141 / Bremelanotide , a fragment of Melanotan II targeted at MC4R, was developed as a sexual stimulant and in 2019 approved as Vyleesi for hypoactive sexual desire disorder in women (HSDD) Second life in research and the cosmetic underground Melanotan II never reached commercial approval as a drug, but in the research community and cosmetic underground it became well known
Speculum exam when indicated (discharge, bleeding, dyspareunia with red flags)
patented anti-oxidant blend of white, red and green tea extracts combined with goji berry, pomegranate, and grape seed extracts to help prevent the visible signs of premature aging
All treatments are prescribed and monitored by licensed medical professionals
With the advent of skin tightening devices, virtually any patient in their thirties or above can be a candidate for a little tightening and firming and the younger the patient the better the result
CJC-1295, sometimes referred to as a growth hormonereleasing hormone (GHRH) analog, is a modified version of GHRH (1-29) designed for extended stability in laboratory settings